WASHINGTON, April 18, 2013 /PRNewswire/ -- Vanda
Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA), a biopharmaceutical
company focused on the development and commercialization of
products for the treatment of central nervous system disorders,
today announced it will release results for the first quarter of
2013 on Thursday, May 9, 2013, before
the market opens.
The Company will host a conference call at 10:00 AM ET on Thursday,
May 9, 2013, during which Vanda management will discuss the
financial results. To participate in the conference call,
please dial 1-877-280-4962 (domestic) or 1-857-244-7319
(international) and use passcode 32610810.
The conference call will be broadcast simultaneously and
archived on the Company's website, www.vandapharma.com.
Investors should go to the website at least 15 minutes early
to register, download, and install any necessary audio
software.
A replay of the call will be available on Thursday, May 9, 2013, beginning at 12:00 PM ET and will be accessible until
Thursday, May 16, 2013, at
5:00 PM ET. The replay call-in
number is 1-888-286-8010 for domestic callers and 1-617-801-6888
for international callers. The passcode number is
47460221.
ABOUT VANDA PHARMACEUTICALS INC.:
Vanda
Pharmaceuticals Inc. is a biopharmaceutical company focused on the
development and commercialization of products for the treatment of
central nervous system disorders. For more on Vanda
Pharmaceuticals Inc., please visit www.vandapharma.com.
Company
Contact:
Jim Kelly
Senior Vice President & Chief Financial
Officer
Vanda Pharmaceuticals
Inc.
(202)
734-3428
jim.kelly@vandapharma.com
SOURCE Vanda Pharmaceuticals Inc.